Effects of KB-R9032, a new Na+/H+ exchange inhibitor, on canine coronary occlusion/reperfusion-induced ventricular arrhythmias

Journal of Pharmacological Sciences

Volumn 98, Issue 4, 2005, Pages 404-410

  Yamada, Chikaomi ^a,b   Xue, Yixue ^a   Chino, Daisuke ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Arrhythmia ischemia; Arrhythmia reperfusion; Ca2+ overload; KB R9032; Na+ H+ exchange

Indexed keywords

1 (3,4 DIHYDRO 4 ISOPROPYL 2,2 DIMETHYL 3 OXO 2H 1,4 BENZOXAZINE 6 CARBONYL)GUANIDINE; PENTOBARBITAL; SODIUM PROTON EXCHANGE PROTEIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTON SODIUM EXCHANGE; QRS COMPLEX; QT INTERVAL; REPERFUSION INJURY;

EID: 24744433374     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050278     Document Type: Article

References (34)

1. Pierce GN, Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol. 1995;27:53-63.
2. 2+ exchange. Circ Res. 1989;65:1045-1056.
3. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042.
4. Clusin WT, Buchbinder M, Harrison DC. Calcium overload, "injury" current, and early ischaemic cardiac arrhythmias - a direct connection. Lancet. 1983;1:272-274.
5. + exchange. Circ Res. 1990;66:1156-1159.
6. + exchange inhibitors in cardiac coronary occlusion. J Mol Cell Cardiol. 1992;24:731-740.
7. + exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol. 1993;109:562-568.
8. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-268.
9. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol. 1994;267:H2430-H2440.
10. + exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol. 2000;396:119-124.
11. Wu D, Stassen JM, Seidler R, Doods H. Effects of BIIB513 on ischemia-induced arrhythmias and myocardial infarction in anesthetized rats. Basic Res Cardiol. 2000;95:449-456.
12. + exchange inhibitor, on ischemia/ reperfusion injury. Eur J Pharmacol. 2000;404:221-229.
13. + exchange inhibitor, on reperfusioninduced ventricular arrhythmias in anesthetized rat. Jpn J Pharmacol. 2002;88:93-99.
14. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur J Pharmacol. 1996;317:309-316.
15. + exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts. Eur J Pharmacol. 1997;339:121-127.
16. Yamamoto T, Hori M, Watanabe I, Tsutsui H, Harada K, Ikeda S, et al. Synthesis and quantitative structure-activity relationships of N-(3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbonyl)guanidines as Na/H exchange inhibitors. Chem Pharm Bull (Tokyo). 1998;46:1716-1723.
17. + exchange inhibitor, for NHE isoforms expressed in a fibroblast cell line. Jpn J Pharmacol. 1998;76 Suppl I:170P.
18. + exchange inhibitor, KBR-9032, on cardiac ischemia-reperfusion injury in rats. Jpn J Pharmacol. 1997;73 Suppl I:232P.
19. Hashimoto K, Haruno A, Matsuzaki T, Hirasawa T, Awaji T, Uemura Y. Effects of a new class III antiarrhythmic drug (E-4031) on canine ventricular arrhythmia models. Asia Pacific J Pharmacol. 1991;6:127-137.
20. Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation. 1981;63:70-79.
21. 2+]i load after ischemia and improves function in intact hearts. Am J Physiol Heart Circ Physiol. 2001;281:H2398-H2409.
22. Schömig A. Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation. 1990;82 Suppl II:13-22.
23. Schömig A, Haass M, Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J. 1991;12 Suppl F:38-47.
24. 1- receptors and α2-adrenoceptors. Circ Res. 1996;78:475-481.
25. Yasutake M, Avkiran M. Exacerbation of reperfusion arrhythmias by α1 adrenergic stimulation: a potential role for receptor mediated activation of sarcolemmal sodium-hydrogen exchange. Cardiovasc Res. 1995;29:222-230.
26. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol. 1994;267:H2430-H2440.
27. Schömig A, Dart AM, Dietz R, Mayer E, Kubler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res. 1984;55:689-701.
28. Kurz T, Richardt G, Hagl S, Seyfarth M, Schomig A. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Mol Cell Cardiol. 1995;27:1161-1172.
29. 1A- adrenoceptor subtype. Circ Res. 1998;82:1078-1085.
30. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther. 1997;283:494-500.
31. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-268.
32. Aye NN, Komori S, Hashimoto K. Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo. Br J Pharmacol. 1999;127:1048-1055.
33. Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J Pharmacol Exp Ther. 1998;286:175-183.
34. Gazmuri RJ, Ayoub IM, Kolarova JD, Karmazyn M. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med. 2002;30:S166-S171.